Lv1
10 积分 2023-02-25 加入
PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
2个月前
已完结
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
3个月前
已完结
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
3个月前
已完结
Twenty-years experience withde novometastatic breast cancer
4个月前
已完结
Trends in Metastatic Breast and Prostate Cancer — Lessons in Cancer Dynamics
4个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
4个月前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
5个月前
已完结
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis
6个月前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
6个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
6个月前
已完结
皖公网安备34019202002308
